Literature DB >> 19697379

Sensitivity of electrophysiological tests for upper and lower motor neuron dysfunction in ALS: a six-month longitudinal study.

Mamede de Carvalho1, Michael Swash.   

Abstract

By following a group of amyotrophic lateral sclerosis (ALS) patients longitudinally using lower motor neuron (LMN) and upper motor neuron (UMN) markers of dysfunction it may be possible to better understand the functional relationships between these motor systems in this disease. We used neurophysiological techniques to follow UMN and LMN dysfunction in a group of 28 patients with ALS, in comparison with the ALS functional rating scale (ALS-FRS) score and the forced vital capacity (FVC). We used motor unit number estimation (MUNE), compound muscle action potential (CMAP) amplitude, and the Neurophysiological Index (NI) to quantify the LMN disorder, and transcranial motor stimulation to study cortical motor threshold, motor-evoked response amplitude, central motor conduction time, and cortical silent period (CSP). The patients were studied shortly after diagnosis and then 6 months later, using both abductor digiti minimi muscles (ADM); ADM strength was initially >MRC 3 (Medical Research Council, UK). The NI and MUNE changed more than any other variable. CSP increased by about 30%, a change more marked than the slight increase observed in the cortical motor threshold (9%). The normal increase of CSP after acute muscle fatigue was preserved during disease progression. The CSP increase correlated with the MUNE rate of decay but not to the NI reduction, perhaps because NI includes F-wave frequency in itscalculation. There was no definite correlation between UMN and LMNdysfunction or progression, but there was a link between CSP and LMN changes in ALS. The CSP may be a useful variable in following UMN dysfunction in clinical practice and in clinical trials.

Entities:  

Mesh:

Year:  2010        PMID: 19697379     DOI: 10.1002/mus.21495

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  12 in total

1.  Techniques and applications of EMG: measuring motor units from structure to function.

Authors:  Rachel C Thornton; Andrew W Michell
Journal:  J Neurol       Date:  2012-01-25       Impact factor: 4.849

Review 2.  How can we improve clinical trials in amyotrophic lateral sclerosis?

Authors:  Paul H Gordon; Vincent Meininger
Journal:  Nat Rev Neurol       Date:  2011-09-27       Impact factor: 42.937

3.  Beyond fractional anisotropy in amyotrophic lateral sclerosis: the value of mean, axial, and radial diffusivity and its correlation with electrophysiological conductivity changes.

Authors:  Ana Filipa Geraldo; João Pereira; Pedro Nunes; Sofia Reimão; Rita Sousa; Miguel Castelo-Branco; Susana Pinto; Jorge Guedes Campos; Mamede de Carvalho
Journal:  Neuroradiology       Date:  2018-03-22       Impact factor: 2.804

Review 4.  Management of respiratory symptoms in ALS.

Authors:  Orla Hardiman
Journal:  J Neurol       Date:  2010-11-17       Impact factor: 4.849

Review 5.  The application of biomarkers in clinical trials for motor neuron disease.

Authors:  Jeban Ganesalingam; Robert Bowser
Journal:  Biomark Med       Date:  2010-04       Impact factor: 2.851

6.  Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis.

Authors:  Eleonora Colombo; Alberto Doretti; Francesco Scheveger; Alessio Maranzano; Giulia Pata; Delia Gagliardi; Megi Meneri; Stefano Messina; Federico Verde; Claudia Morelli; Stefania Corti; Luca Maderna; Vincenzo Silani; Nicola Ticozzi
Journal:  J Neurol       Date:  2022-10-02       Impact factor: 6.682

Review 7.  Electrodiagnosis in persons with amyotrophic lateral sclerosis.

Authors:  Nanette C Joyce; Gregory T Carter
Journal:  PM R       Date:  2013-03-21       Impact factor: 2.298

8.  Cortical hyperexcitability in patients with C9ORF72 mutations: Relationship to phenotype.

Authors:  Olivia Schanz; Devin Bageac; Laura Braun; Bryan J Traynor; Tanya J Lehky; Mary Kay Floeter
Journal:  Muscle Nerve       Date:  2016-05-25       Impact factor: 3.217

Review 9.  Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.

Authors:  Robert Bowser; Martin R Turner; Jeremy Shefner
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

10.  Does the MUNIX Method Reflect Clinical Dysfunction in Amyotrophic Lateral Sclerosis: A Practical Experience.

Authors:  Malgorzata Gawel; Magdalena Kuzma-Kozakiewicz
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.